Posted in | News | Green Hydrogen

Nel ASA: Awarded EUR 135 Million in Grants for Industrialization of Next-Generation Electrolyser Technology in Norway

(October 22, 2024 - Oslo, Norway) Nel Hydrogen Electrolyser AS, a fully owned subsidiary of Nel ASA (Nel, OSE:NEL), has today been awarded a grant from the EU Innovation Fund of up to EUR 135 million for industrialization of its next-generation pressurized alkaline technology. The technology is currently being prototyped, and the potential industrialization is planned at Herøya, Norway.

“We continue to realize the full potential of our current technology at the same time as we develop future technologies to help our customers drive down the cost of green hydrogen. This grant will make it significantly easier for us to bring our new innovative pressurized alkaline technology to market,” said Nel’s President and CEO, Håkon Volldal.

Nel has been developing its next-generation pressurized alkaline technology for more than five years. The technology is currently in the prototype stage with promising results. Nel has now been awarded a grant for a phased build-out of production at Herøya, Norway. The grant application was supported by Enova SF, the Norwegian national contact point for the EU Innovation Fund.

“Building on nearly 100 years of electrolyser innovation, we have developed this new, differentiated technology that will be a step-change in cost and performance for renewable hydrogen. Bringing a new technology to market always entails risk, and we are thankful for the support we have previously received from the Research Council of Norway and Innovation Norway. With this substantially larger grant from the EU Innovation Fund, we will be able to bring the innovation to market at an accelerated pace,” Volldal says.

The initial build-out is planned for an annual capacity of 1-2 GW, utilizing existing space at Nel’s current facility in Herøya, Norway. The support will be phased with Nel’s own investments for up to 4 GW of capacity for pressurized electrolyser equipment in Norway. A final investment decision to start building the capacity depends on achieving successful testing in the current prototype and planned pilot stage, as well as market acceptance of the new technology.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nel Hydrogen. (2024, November 12). Nel ASA: Awarded EUR 135 Million in Grants for Industrialization of Next-Generation Electrolyser Technology in Norway. AZoCleantech. Retrieved on November 24, 2024 from https://www.azocleantech.com/news.aspx?newsID=35318.

  • MLA

    Nel Hydrogen. "Nel ASA: Awarded EUR 135 Million in Grants for Industrialization of Next-Generation Electrolyser Technology in Norway". AZoCleantech. 24 November 2024. <https://www.azocleantech.com/news.aspx?newsID=35318>.

  • Chicago

    Nel Hydrogen. "Nel ASA: Awarded EUR 135 Million in Grants for Industrialization of Next-Generation Electrolyser Technology in Norway". AZoCleantech. https://www.azocleantech.com/news.aspx?newsID=35318. (accessed November 24, 2024).

  • Harvard

    Nel Hydrogen. 2024. Nel ASA: Awarded EUR 135 Million in Grants for Industrialization of Next-Generation Electrolyser Technology in Norway. AZoCleantech, viewed 24 November 2024, https://www.azocleantech.com/news.aspx?newsID=35318.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.